Pulsed ultrasound measurements of depth and regression of basal cell carcinomas after photodynamic therapy: Relationship to probability of 1-year local control

British Journal of Dermatology

Volumn 149, Issue 5, 2003, Pages 1035-1040

  Moore, J V ^a   Allan, E ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Aminolaevulinic acid; Basal cell carcinoma; Photodynamic therapy; Pulsed ultrasound

Indexed keywords

AMINOLEVULINIC ACID;

AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER CONTROL; CANCER RECURRENCE; DEVICE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKINFOLD THICKNESS; TREATMENT OUTCOME; ULTRASOUND;

AGED; CARCINOMA, BASAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PHOTOCHEMOTHERAPY; PROGNOSIS; REMISSION INDUCTION; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 0347382295     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2003.05558.x     Document Type: Article

References (14)

1. Edwards C, Al-Aboosi MM, Marks R. The use of A-scan ultrasound in the assessment of small skin tumours. Br J Dermatol 1989; 121: 297-304.
2. Fornage BD, McGavran MH, Duvic M, Waldron CA. Imaging of the skin with 20-MHz US. Radiology 1993; 189: 69-76.
3. Moran CM, Bush NL, Bamber JC. Ultrasonic propagation properties of excised human skin. Ultrasound Med Biol 1995; 21: 1177-90.
4. Morton CA, MacKie RM, Whitehurst C et al. Photodynamic therapy for basal cell carcinoma: effect of tumour thickness and duration of photosensitiser application on response. Arch Dermatol 1998; 134: 248-9.
5. Varma S, Wilson H, Kurwa HA et al. Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source. Br J Dermatol 2001; 144: 567-74.
6. Haller JC, Cairnduff F, Slack G et al. Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid-based photodynamic therapy. Br J Dermatol 2000; 143: 1270-4.
7. Whitehurst C, Byrne K, Moore JV. Development of an alternative light source to lasers for photodynamic therapy: 1. Comparative in vitro dose response characteristics. Lasers Med Sci 1993; 8: 259-67.
8. Peng Q, Warloe T, Berg K et al. 5-ALA based photodynamic therapy. Cancer 1997; 79: 2282-308.
9. Morton CA, Brown SB, Collins S et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 2002; 146: 552-67.
10. Allan E, Pye DA, Levine EL, Moore JV. Non-invasive pulsed ultrasound quantification of the resolution of basal cell carcinomas after photodynamic therapy. Lasers Med Sci 2002; 17: 230-7.
11. Peng Q, Soler AM, Warloe T, Nesland JM. Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Photochem Photobiol B Biol 2001; 62: 140-5.
12. Warloe T, Heyerdahl H, Peng Q, Giercksky K-E. Photodynamic therapy with 5-aminolaevulinic acid induced porphyrins and skin penetration enhancer for basal cell carcinoma. SPIE 1994; 2371: 226-35.
13. Thissen MR, Schroeter CA, Neumann HA. Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique. Br J Dermatol 2000; 142: 338-9.
14. Soler AM, Warloe T, Tausjo J, Berner A. Photodynamic therapy by topical aminolaevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one year follow-up study. Acta Derm Venereol (Stockh) 1999; 79: 204-6.